Weijing Sun. Molecular subtypes of colorectal cancer: Evaluation of outcomes and treatment. Oncol Transl Med, 2016, 2: 145-149.
Molecular subtypes of colorectal cancer: Evaluation of outcomes and treatment
Received:June 08, 2016  Revised:July 28, 2016
View Full Text  View/Add Comment  Download reader
KeyWord:colorectal cancer (CRC); molecular subtype; evaluation
Author NameAffiliationE-mail
Weijing Sun University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center (UPMC), University of Pittsburgh Cancer Institute (UPCI) sunw@upmc.edu 
Hits: 6335
Download times: 7890
Abstract:
      Colorectal cancer (CRC) is a biologically heterogeneous disease with diverse clinical outcomes and responses to treatment. In the past two to three decades, a major effort has focused on classifying colorectal cancer subtypes based on causation, etiology, gene expression profiles, different pathways, and translational data from clinical trials. The goal is to uncover prognostic and predictive factors for outcomes in patients with colorectal cancer and to guide therapeutic approaches and management for the improvement of overall survival. Significant advances have been achieved in this area. However, tremendous work is still needed to accomplish the goal of better understanding intratumoral heterogeneity and the influence of the colonic environment, among other facets of colorectal cancer.
Close